A Randomized, Evaluator-Blind, Phase 2 Study Comparing the Safety and Efficacy of Omadacycline to Those of Linezolid for Treatment of Complicated Skin and Skin Structure Infections

A randomized, investigator-blind, multicenter phase 2 trial involving patients with complicated skin and skin structure infections (cSSSI) compared the safety and efficacy of omadacycline, a broad-spectrum agent with activity against methicillin-resistant Staphylococcus aureus (MRSA), to those of li...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Noel, Gary J., Draper, Michael P., Hait, Howard, Tanaka, S. Ken, Arbeit, Robert D.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology 2012
Témata:
Clinical Therapeutics
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3486554/
https://ncbi.nlm.nih.gov/pubmed/22908151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00948-12
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky